Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM)[1][2].
Molecular Weight:
419.38
Purity:
99.85
CAS Number:
[1051375-16-6]
Formula:
C20H19F2N3O5
Target:
HIV,HIV Integrase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
